(UNVB) Unilever - Ratings and Ratios
Shampoo, Soap, Deodorant, Ice Cream, Seasoning
UNVB EPS (Earnings per Share)
UNVB Revenue
Description: UNVB Unilever
Unilever PLC (XETRA: UNVB) is a global fast-moving consumer goods (FMCG) group operating across Asia-Pacific, Africa, the Americas and Europe. Its portfolio is split into five segments – Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream – covering product categories from hair-care and skin-care to detergents, sauces and frozen desserts, marketed under more than 50 household brands such as Dove, Knorr, Ben & Jerry’s and Magnum.
According to the FY 2023 results (the most recent full-year data available as of October 2025), Unilever generated €60.1 billion in underlying sales, a 2.2 % organic growth year-on-year, and delivered an underlying operating margin of 15.5 %. Free cash flow stood at €5.5 billion, supporting a dividend yield of roughly 3.5 % and a payout ratio near 80 %. These figures suggest modest top-line expansion but a solid cash conversion profile, which is a key driver of shareholder returns in the mature FMCG sector.
Key economic and sector drivers that will shape Unilever’s performance include: (1) commodity price volatility – especially for palm oil, dairy and packaging materials – which directly impacts cost-of-goods-sold and margin pressure; (2) inflation-driven consumer price sensitivity, prompting a shift toward value-oriented SKUs and promotional activity in emerging markets; and (3) the accelerating migration to e-commerce and direct-to-consumer channels, which is reshaping distribution economics and enabling premium-price positioning for “beauty-wellbeing” and “ice-cream” sub-segments. A deviation from any of these trends (e.g., a sustained drop in raw-material prices or a faster-than-expected digital adoption curve) would materially alter the outlook.
For a deeper, data-driven valuation snapshot, the ValueRay platform provides a concise, up-to-date analysis that may help you assess UNVB’s risk-adjusted upside.
UNVB Stock Overview
| Market Cap in USD | 145,466m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
UNVB Stock Ratings
| Growth Rating | 21.9% |
| Fundamental | 79.0% |
| Dividend Rating | 47.2% |
| Return 12m vs S&P 500 | -17.9% |
| Analyst Rating | - |
UNVB Dividends
| Dividend Yield 12m | 3.81% |
| Yield on Cost 5y | 4.52% |
| Annual Growth 5y | 0.25% |
| Payout Consistency | 97.8% |
| Payout Ratio | 72.7% |
UNVB Growth Ratios
| Growth Correlation 3m | -9.2% |
| Growth Correlation 12m | -44.5% |
| Growth Correlation 5y | 78.3% |
| CAGR 5y | 8.21% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.62 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.50 |
| Sharpe Ratio 12m | -0.22 |
| Alpha | -12.46 |
| Beta | 0.247 |
| Volatility | 14.39% |
| Current Volume | 10k |
| Average Volume 20d | 13.6k |
| Stop Loss | 51.3 (-3.2%) |
| Signal | 1.08 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (11.13b TTM) > 0 and > 6% of Revenue (6% = 6.39b TTM) |
| FCFTA 0.14 (>2.0%) and ΔFCFTA -1.62pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -5.55% (prev -6.27%; Δ 0.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 12.59b > Net Income 11.13b (YES >=105%, WARN >=100%) |
| Net Debt (-4.34b) to EBITDA (21.56b) ratio: -0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.47b) change vs 12m ago -2.17% (target <= -2.0% for YES) |
| Gross Margin 68.63% (prev 16.63%; Δ 52.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 140.7% (prev 118.8%; Δ 21.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.18 (EBITDA TTM 21.56b / Interest Expense TTM 1.66b) >= 6 (WARN >= 3) |
Altman Z'' 4.27
| (A) -0.08 = (Total Current Assets 19.19b - Total Current Liabilities 25.10b) / Total Assets 76.00b |
| (B) 0.67 = Retained Earnings (Balance) 50.70b / Total Assets 76.00b |
| (C) 0.25 = EBIT TTM 18.60b / Avg Total Assets 75.63b |
| (D) 0.91 = Book Value of Equity 50.79b / Total Liabilities 56.07b |
| Total Rating: 4.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.95
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 7.18% = 3.59 |
| 3. FCF Margin 10.22% = 2.55 |
| 4. Debt/Equity 1.80 = 1.06 |
| 5. Debt/Ebitda -0.20 = 2.50 |
| 6. ROIC - WACC (= 42.08)% = 12.50 |
| 7. RoE 56.81% = 2.50 |
| 8. Rev. Trend 37.79% = 2.83 |
| 9. EPS Trend -11.93% = -0.60 |
What is the price of UNVB shares?
Over the past week, the price has changed by +4.17%, over one month by +0.88%, over three months by +3.72% and over the past year by -5.67%.
Is Unilever a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UNVB is around 45.91 EUR . This means that UNVB is currently overvalued and has a potential downside of -13.34%.
Is UNVB a buy, sell or hold?
What are the forecasts/targets for the UNVB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.9 | -5.8% |
UNVB Fundamental Data Overview
Market Cap EUR = 124.70b (124.70b EUR * 1.0 EUR.EUR)
P/E Trailing = 22.7054
P/E Forward = 15.3139
P/S = 2.0863
P/B = 6.9692
P/EG = 1.6818
Beta = 0.247
Revenue TTM = 106.45b EUR
EBIT TTM = 18.60b EUR
EBITDA TTM = 21.56b EUR
Long Term Debt = 23.29b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 7.16b EUR (from shortTermDebt, last quarter)
Debt = 32.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.34b EUR (from netDebt column, last quarter)
Enterprise Value = 151.42b EUR (124.70b + Debt 32.02b - CCE 5.31b)
Interest Coverage Ratio = 11.18 (Ebit TTM 18.60b / Interest Expense TTM 1.66b)
FCF Yield = 7.18% (FCF TTM 10.88b / Enterprise Value 151.42b)
FCF Margin = 10.22% (FCF TTM 10.88b / Revenue TTM 106.45b)
Net Margin = 10.46% (Net Income TTM 11.13b / Revenue TTM 106.45b)
Gross Margin = 68.63% ((Revenue TTM 106.45b - Cost of Revenue TTM 33.39b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 94.16%)
Tobins Q-Ratio = 1.99 (Enterprise Value 151.42b / Total Assets 76.00b)
Interest Expense / Debt = 1.70% (Interest Expense 545.8m / Debt 32.02b)
Taxrate = 25.17% (1.28b / 5.09b)
NOPAT = 13.92b (EBIT 18.60b * (1 - 25.17%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.10b)
Debt / Equity = 1.80 (Debt 32.02b / totalStockholderEquity, last quarter 17.80b)
Debt / EBITDA = -0.20 (Net Debt -4.34b / EBITDA 21.56b)
Debt / FCF = -0.40 (Net Debt -4.34b / FCF TTM 10.88b)
Total Stockholder Equity = 19.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.65% (Net Income 11.13b / Total Assets 76.00b)
RoE = 56.81% (Net Income TTM 11.13b / Total Stockholder Equity 19.60b)
RoCE = 43.37% (EBIT 18.60b / Capital Employed (Equity 19.60b + L.T.Debt 23.29b))
RoIC = 47.86% (NOPAT 13.92b / Invested Capital 29.09b)
WACC = 5.77% (E(124.70b)/V(156.73b) * Re(6.93%) + D(32.02b)/V(156.73b) * Rd(1.70%) * (1-Tc(0.25)))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.09%
[DCF Debug] Terminal Value 78.42% ; FCFE base≈11.32b ; Y1≈11.43b ; Y5≈12.35b
Fair Price DCF = 88.95 (DCF Value 218.08b / Shares Outstanding 2.45b; 5y FCF grow 0.52% → 3.0% )
EPS Correlation: -11.93 | EPS CAGR: -70.54% | SUE: 0.0 | # QB: 0
Revenue Correlation: 37.79 | Revenue CAGR: 29.46% | SUE: N/A | # QB: 0